273 related articles for article (PubMed ID: 29654896)
41. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
Zhang L; Yao J; Zhou J; Wang T; Zhang Q
Int J Pharm; 2013 Jan; 441(1-2):654-64. PubMed ID: 23117024
[TBL] [Abstract][Full Text] [Related]
42. Improved druggability of gambogic acid using core-shell nanoparticles.
Liu F; Huang X; Han L; Sang M; Hu L; Liu B; Duan B; Jiang P; Wang X; Qiao Z; Ma C; Liu W; Liu J; Feng F; Qu W
Biomater Sci; 2019 Feb; 7(3):1028-1042. PubMed ID: 30608065
[TBL] [Abstract][Full Text] [Related]
43. Optimization and anticancer activity in vitro and in vivo of baohuoside I incorporated into mixed micelles based on lecithin and Solutol HS 15.
Yan HM; Song J; Zhang ZH; Jia XB
Drug Deliv; 2016 Oct; 23(8):2911-2918. PubMed ID: 26644047
[TBL] [Abstract][Full Text] [Related]
44. Celastrol-loaded polymeric mixed micelles shows improved antitumor efficacy in 4 T1 bearing xenograft mouse model through spatial targeting.
Gautam S; Singh N; Marwaha D; Rai N; Sharma M; Tiwari P; Singh S; Kumar Bakshi A; Kumar A; Agarwal N; Prakash Shukla R; Ranjan Mishra P
Int J Pharm; 2024 Jun; 659():124234. PubMed ID: 38763310
[TBL] [Abstract][Full Text] [Related]
45. Liver-Targeting and pH-Sensitive Sulfated Hyaluronic Acid Mixed Micelles for Hepatoma Therapy.
Li ZP; Tian GX; Jiang H; Pan RY; Lian B; Wang M; Gao ZQ; Zhang B; Wu JL
Int J Nanomedicine; 2019; 14():9437-9452. PubMed ID: 31819442
[TBL] [Abstract][Full Text] [Related]
46. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
[TBL] [Abstract][Full Text] [Related]
47. Redox-responsive micelles from disulfide bond-bridged hyaluronic acid-tocopherol succinate for the treatment of melanoma.
Xia J; Du Y; Huang L; Chaurasiya B; Tu J; Webster TJ; Sun C
Nanomedicine; 2018 Apr; 14(3):713-723. PubMed ID: 29317344
[TBL] [Abstract][Full Text] [Related]
48. Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake.
Zheng S; Jin Z; Han J; Cho S; Nguyen VD; Ko SY; Park JO; Park S
Colloids Surf B Biointerfaces; 2016 Jul; 143():27-36. PubMed ID: 26998864
[TBL] [Abstract][Full Text] [Related]
49. Novel polymeric micelles as enzyme-sensitive nuclear-targeted dual-functional drug delivery vehicles for enhanced 9-nitro-20(S)-camptothecin delivery and antitumor efficacy.
Sun Y; Liang Y; Hao N; Fu X; He B; Han S; Cao J; Ma Q; Xu W; Sun Y
Nanoscale; 2020 Mar; 12(9):5380-5396. PubMed ID: 32022069
[TBL] [Abstract][Full Text] [Related]
50. Improving aqueous solubility and antitumor effects by nanosized gambogic acid-mPEG₂₀₀₀ micelles.
Cai L; Qiu N; Xiang M; Tong R; Yan J; He L; Shi J; Chen T; Wen J; Wang W; Chen L
Int J Nanomedicine; 2014; 9():243-55. PubMed ID: 24403830
[TBL] [Abstract][Full Text] [Related]
51. Novel Chitosan Derivatives with Reversible Cationization and Hydrophobicization for Tumor Cytoplasm-Specific Burst Co-delivery of siRNA and Chemotherapeutics.
Yin T; Liu Y; Yang M; Wang L; Zhou J; Huo M
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14770-14783. PubMed ID: 32149497
[TBL] [Abstract][Full Text] [Related]
52. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.
Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB
Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247
[TBL] [Abstract][Full Text] [Related]
53. Gambogic acid-loaded electrosprayed particles for site-specific treatment of hepatocellular carcinoma.
Yin D; Yang Y; Cai H; Wang F; Peng D; He L
Mol Pharm; 2014 Nov; 11(11):4107-17. PubMed ID: 25290462
[TBL] [Abstract][Full Text] [Related]
54. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
Zhang B; Zhang Y; Yu D
Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442
[TBL] [Abstract][Full Text] [Related]
55. A Combined Self-Assembled Drug Delivery for Effective Anti-Breast Cancer Therapy.
Wang H; Zhang Y; Zeng X; Pei W; Fan R; Wang Y; Wang X; Li J
Int J Nanomedicine; 2021; 16():2373-2388. PubMed ID: 33790555
[TBL] [Abstract][Full Text] [Related]
56. Mitochondrial targeting nanodrugs self-assembled from 9-O-octadecyl substituted berberine derivative for cancer treatment by inducing mitochondrial apoptosis pathways.
Song J; Lin C; Yang X; Xie Y; Hu P; Li H; Zhu W; Hu H
J Control Release; 2019 Jan; 294():27-42. PubMed ID: 30445003
[TBL] [Abstract][Full Text] [Related]
57. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
[TBL] [Abstract][Full Text] [Related]
58. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer.
Zhang D; Zou Z; Ren W; Qian H; Cheng Q; Ji L; Liu B; Liu Q
Pharm Dev Technol; 2018 Jan; 23(1):33-40. PubMed ID: 29069711
[TBL] [Abstract][Full Text] [Related]
59. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
[TBL] [Abstract][Full Text] [Related]
60. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
